Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zorayr Manukyan

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Clinical Pharmacology|October 13, 2017
Application of Quantitative Pharmacology Approaches in Bridging Pharmacokinetics and Pharmacodynamics of Domagrozumab From Adult Healthy Subjects to Pediatric Patients With Duchenne Muscular DiseaseIndranil Bhattacharya, Zorayr Manukyan, Phylinda Chan, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 6, 2022
Timing of hypotensive adverse events in U.S. source plasma donors: Exploratory analysis from the IMPACT trialJan Hartmann, Michael J Ragusa, Zorayr Manukyan, et al.
Transfusion|October 15, 2023
Large-scale real-world data analysis of source plasma collections using a novel technology-enabled nomogramEva Hellman, Zorayr Manukyan, Karen Mkhitaryan, et al.
Transfusion|March 24, 2021
Personalized collection of plasma from healthy donors: A randomized controlled trial of a novel technology-enabled nomogramJan Hartmann, Michael J Ragusa, Elmar R Burchardt, et al.
Transfusion|July 26, 2021
Repeat donation and deferral rates in US source plasma donors: Exploratory analysis from the IMPACT trialJan Hartmann, Michael J Ragusa, Elmar R Burchardt, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Statistical Monitoring in Clinical Trials: Best Practices for Detecting Data Anomalies Suggestive of Fabrication or MisconductDavid Knepper, Anne S Lindblad, Gaurav Sharma, et al.
Arthritis Research & Therapy|December 7, 2019
Safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06650833, a selective interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, in single and multiple ascending dose randomized phase 1 studies in healthy subjectsSpencer I Danto, Negin Shojaee, Ravi Shankar P Singh, et al.
Clinical Trials (London, England)|December 4, 2013
Central site monitoring: results from a test of accuracy in identifying trials and sites failing Food and Drug Administration inspectionAnne S Lindblad, Zorayr Manukyan, Tejashri Purohit-Sheth, et al.
Journal of Clinical and Experimental Neuropsychology|January 7, 2015
Fasting glucose and glucose tolerance as potential predictors of neurocognitive function among nondiabetic older adultsRegina Sims Wright, Shellie-Anne T Levy, Leslie I Katzel, et al.
American Journal of Clinical Pathology|July 29, 2024
TEG® 6s coagulation testing with a novel heparin neutralization cartridge: Technical validation and determination of normal reference rangesJan Hartmann, Joao Dias, Alexandra Shilo, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Clinical Pharmacology|October 13, 2017
Application of Quantitative Pharmacology Approaches in Bridging Pharmacokinetics and Pharmacodynamics of Domagrozumab From Adult Healthy Subjects to Pediatric Patients With Duchenne Muscular DiseaseIndranil Bhattacharya, Zorayr Manukyan, Phylinda Chan, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 6, 2022
Timing of hypotensive adverse events in U.S. source plasma donors: Exploratory analysis from the IMPACT trialJan Hartmann, Michael J Ragusa, Zorayr Manukyan, et al.
Transfusion|October 15, 2023
Large-scale real-world data analysis of source plasma collections using a novel technology-enabled nomogramEva Hellman, Zorayr Manukyan, Karen Mkhitaryan, et al.
Transfusion|March 24, 2021
Personalized collection of plasma from healthy donors: A randomized controlled trial of a novel technology-enabled nomogramJan Hartmann, Michael J Ragusa, Elmar R Burchardt, et al.
Transfusion|July 26, 2021
Repeat donation and deferral rates in US source plasma donors: Exploratory analysis from the IMPACT trialJan Hartmann, Michael J Ragusa, Elmar R Burchardt, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Statistical Monitoring in Clinical Trials: Best Practices for Detecting Data Anomalies Suggestive of Fabrication or MisconductDavid Knepper, Anne S Lindblad, Gaurav Sharma, et al.
Arthritis Research & Therapy|December 7, 2019
Safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06650833, a selective interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, in single and multiple ascending dose randomized phase 1 studies in healthy subjectsSpencer I Danto, Negin Shojaee, Ravi Shankar P Singh, et al.
Clinical Trials (London, England)|December 4, 2013
Central site monitoring: results from a test of accuracy in identifying trials and sites failing Food and Drug Administration inspectionAnne S Lindblad, Zorayr Manukyan, Tejashri Purohit-Sheth, et al.
Journal of Clinical and Experimental Neuropsychology|January 7, 2015
Fasting glucose and glucose tolerance as potential predictors of neurocognitive function among nondiabetic older adultsRegina Sims Wright, Shellie-Anne T Levy, Leslie I Katzel, et al.
American Journal of Clinical Pathology|July 29, 2024
TEG® 6s coagulation testing with a novel heparin neutralization cartridge: Technical validation and determination of normal reference rangesJan Hartmann, Joao Dias, Alexandra Shilo, et al.
Pageof 2